We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
ResoTher Pharma awarded EU Horizon 2020 award
ResoTher Pharma is excited to announce that the company has [...]
ResoTher Pharma and Queen Mary University London wins Translational Research grant from Barts Charity, UK
ResoTher Pharma and Professor Mauro Perretti, William Harvey Research Institute, [...]
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has [...]
Latest News
ResoTher Pharma awarded EU Horizon 2020 award
ResoTher Pharma is excited to announce that the company has [...]
ResoTher Pharma and Queen Mary University London wins Translational Research grant from Barts Charity, UK
ResoTher Pharma and Professor Mauro Perretti, William Harvey Research Institute, [...]
ResoTher Pharma wins Innobooster award
ResoTher Pharma is pleased to announce that the company has [...]
